Clinical TrialsSearch results
Number of results: 815
Other
- Randomized phase II/III study of R-CHOP versus weekly rituximab plus CHOP for CD20 positive diffuse large B cell lymphoma (JCOG0601)
- CD20 positive diffuse large B cell lmyphoma
- Japan Clinical Oncology Group(JCOG)
- 2007-12-04
Other
- Randomized phase II trial of TS-1 monotherapy versus TS-1 plus gemcitabine therapy in patients with gemcitabine-resistant advanced pancreatic cancer
- Patients with unresectable advanced pancreatic cancer (Stage IV, TNM Classification) who were primarily resistant to gemcitabine monotherapy
- Keio University School of Medicine, Department of Medicine, Division of Gastroenterology
- 2008-04-01
Other
- Randomized phase II trial of irinotecan(CPT-11) plus tegafur/uracil with oral leucovorin(UFT/LV) compared with FOLFIRI in patients with unresectable/recurrent colorectal cancer
- Patients with previously untreated and unresectable/recurrent colorectal cancer
- Department of Surgery, School of Medicine, Keio University
- 2007-12-19
Other
- Randomized phase II trial of docetaxel and carboplatin in patients with stage IIIB/IV non-small cell lung cancer.
- Stage IIIB/IV non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-01
Other
- Randomized phase II study of the Induction Chemotherapy with Docetaxel alone vs CDDP+Docetaxel for c-stage IB-II Non-Small Cell Lung Cancer (JCOG 0204-MF)
- pulmonary neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-07-28
Other
- Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2
- Breast Cancer
- Office for cordination of Herceptin trial
- 2007-03-23
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus S-1 in advanced biliary tract cancer. (JCOG 0805)
- biliary tract neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2009-02-04
Other
- Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine in advanced biliary tract cancer (GS-COMBI).
- Advanced biliary tract cancer
- Japanese Endoscopist & IVRists group for Biliary Tract Cancer (JEIBIC)
- 2009-02-12
Other
- Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-08
Other
- Randomized phase II study comparing chemotherapy led by using the classification of primary tumor origin with empirical chemotherapy for patients with unknown primary cancer .
- cancer of unknown primary
- Ministry of Health, Labour and Welfare scientific research Nakagawa squad
- 2009-04-30